SCHEMBL6136596

SCHEMBL6136596

CCC(O)(/C=C/CO)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6136599 1.00
SCHEMBL16358921 0.80
SCHEMBL10899240 0.80
SCHEMBL8053135 0.78 TSHR (0.32)
SCHEMBL8053130 0.78 TSHR (0.32)
SCHEMBL5997799 0.76 ALDH1A1 (0.35)
SCHEMBL5152708 0.76
SCHEMBL7163085 0.76 ALDH1A1 (0.35)
SCHEMBL13301756 0.76 TSHR (0.35)
SCHEMBL5152715 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101830839-A Method for synthesizing Seocalcitol HYDRAGON PHARMA CO LTD 2010-09-15 CN disclosed
EP-1048661-B1 Process for preparing anti-osteoporotic agents HOFFMANN LA ROCHE (CH) 2005-11-30 EP disclosed
US-6255501-B1 PREPARING 3AR-(1(1S*,3E),3A.ALPHA.,7A.BETA.))-1-(5-ETHYL-1-METHYL-5 -((TRIETHYLSILYL)OXY)-3-HEPTENYL)-3,3A,5,6,7,7A-HEXAHYDRO-7A-METHYL-4H-INDEN-4-ONE USEFUL IN TREATING OSTEOPOROSIS HOFFMAN-LA ROCHE INC. 2001-07-03 US disclosed
EP-1048661-A2 Process for preparing anti-osteoporotic agents F. HOFFMANN-LA ROCHE AG (CH) 2000-11-02 EP disclosed
US-3975381-A Process for preparing γ-lactone derivatives SAGAMI CHEMICAL RESEARCH CENTER (JA) 1976-08-17 US disclosed